CHRDL1 was reported to be downregulated in T-ALL (35), gastric cancer (29), thyroid cancer (31–34), lung cancer (25–28), malignant melanoma (36), and breast cancer (22–24). Here, CHRDL1 is linked to lung carcinoma.